Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. Signal., 25 October 2011
Vol. 4, Issue 196, p. ra70
[DOI: 10.1126/scisignal.2002278]

RESEARCH ARTICLES

Editor's Summary

Growing a Heart
Understanding the signaling pathways that regulate heart growth during development provides possible avenues for regenerative therapies. In the fruit fly, the Hippo signaling pathway acts to limit organ size during development, and recent evidence indicates that this pathway also restricts cardiac growth in embryonic mice. Among other targets, activation of Hippo inhibits the transcriptional coactivator Yap. Mice generated by Xin et al. with a cardiomyocyte-specific deficiency of Yap developed smaller hearts and died in utero. In contrast, mice expressing a constitutively active form of Yap in the heart had larger hearts because of increased cell proliferation. In cardiomyocytes, expression of the constitutively active form of Yap increased the activity of the insulin-like growth factor (IGF) pathway, which resulted in stabilization of β-catenin, a transcriptional effector of the Wnt signaling pathway that promotes cardiomyocyte proliferation. Thus, alleviating the Hippo pathway–mediated inhibition of Yap increases the activity of signaling pathways that increase the growth of the heart during development.

Citation: M. Xin, Y. Kim, L. B. Sutherland, X. Qi, J. McAnally, R. J. Schwartz, J. A. Richardson, R. Bassel-Duby, E. N. Olson, Regulation of Insulin-Like Growth Factor Signaling by Yap Governs Cardiomyocyte Proliferation and Embryonic Heart Size. Sci. Signal. 4, ra70 (2011).

Read the Full Text

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1.
R. Fan, N.-G. Kim, and B. M. Gumbiner (2013)
PNAS 110, 2569-2574
   Abstract »    Full Text »    PDF »
Yes-associated Protein Isoform 1 (Yap1) Promotes Cardiomyocyte Survival and Growth to Protect against Myocardial Ischemic Injury.
D. P. Del Re, Y. Yang, N. Nakano, J. Cho, P. Zhai, T. Yamamoto, N. Zhang, N. Yabuta, H. Nojima, D. Pan, et al. (2013)
J. Biol. Chem. 288, 3977-3988
   Abstract »    Full Text »    PDF »
Intersection of Hippo/YAP and Wnt/{beta}-catenin signaling pathways.
W. M. Konsavage Jr and G. S. Yochum (2013)
Acta Biochim Biophys Sin 45, 71-79
   Abstract »    Full Text »    PDF »
In vivo monitoring of cardiomyocyte proliferation to identify chemical modifiers of heart regeneration.
W.-Y. Choi, M. Gemberling, J. Wang, J. E. Holdway, M.-C. Shen, R. O. Karlstrom, and K. D. Poss (2013)
Development 140, 660-666
   Abstract »    Full Text »    PDF »
FoxO1 and FoxM1 Transcription Factors Have Antagonistic Functions in Neonatal Cardiomyocyte Cell-Cycle Withdrawal and IGF1 Gene Regulation.
A. Sengupta, V. V. Kalinichenko, and K. E. Yutzey (2013)
Circ. Res. 112, 267-277
   Abstract »    Full Text »    PDF »
Cardiac Regeneration.
A. Rosenzweig (2012)
Science 338, 1549-1550
   Abstract »    Full Text »    PDF »
14-3-3{varepsilon} Plays a Role in Cardiac Ventricular Compaction by Regulating the Cardiomyocyte Cell Cycle.
Y. Kosaka, K. A. Cieslik, L. Li, G. Lezin, C. T. Maguire, Y. Saijoh, K. Toyo-oka, M. J. Gambello, M. Vatta, A. Wynshaw-Boris, et al. (2012)
Mol. Cell. Biol. 32, 5089-5102
   Abstract »    Full Text »    PDF »
Yap1 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin.
C. Xie, Y. Guo, T. Zhu, J. Zhang, P. X. Ma, and Y. E. Chen (2012)
J. Biol. Chem. 287, 14598-14605
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882